跳至主要内容
临床试验/CTRI/2018/01/011532
CTRI/2018/01/011532尚未招募未知

Effect of 1,25 dihydroxy Vitamin D3 Supplementation on Pain Relief in Early Rheumatoid Arthritis: An 8-week, open-label, parallel randomized trial

Dr Dibyendu Mukherjee0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed Rheumatoid Arthritis (duration less than 2years) subjects, who have not been treated with any medication other than analgesics prior to study recruitment.

排除标准

  • (i) patients who have been on steroids during the past year; (ii) known to have disorders of calcium metabolism such as malabsorption, hyperparathyroidism, chronic renal failure, renal tubular acidosis or pancreatitis; (iii) known allergy to DMARDs, 1,25 dihydroxy vitamin D3 or calcium; (iv) patients unlikely for follow-up in the following 8 weeks; (v) patients unable to afford triple DMARD therapy; (vi) patients who were suspected to have vasculitis; (vii) and patients unable to mark the pain scale.

研究者

发起方
Dr Dibyendu Mukherjee

相似试验